Physician profile
Thomas Curran
NPI 1205147022
$11,482.90
in general payments reported to CMS, 2019-2025
18 companies · $703 in 2025
The $703 reported for 2025 was more than what a typical Colon & Rectal Surgery provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,766 · 2020: $76.73 · 2021: $224 · 2022: $1,897 · 2023: $2,410 · 2024: $406 · 2025: $703.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,382 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $1,000 · Honoraria: $1,000 · Education: $137.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,381.54 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $1,000.00 |
| Honoraria | $1,000.00 |
| Education | $137.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $4,746.23 | 2019-2020 | |
| Davol INC. | $3,601.70 | 2022-2023 | |
| Applied Medical Resources Corporation | $692.78 | 2019 | |
| Solventum Corporation | $305.89 | 2024-2025 | Prevena, V.A.C. Veraflo, Bair Hugger |
| Medical Device Business Services, INC. | $282.01 | 2025 | Echelon Flex |
| Kci USA, INC. | $278.49 | 2019-2023 | V.A.C. Veraflo, Prevena, V.A.C. Dermatac |
| Tela Bio, INC. | $246.84 | 2019-2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $233.90 | 2022-2023 | Entyvio |
| Innovation Technologies INC | $197.55 | 2024 | Irrisept |
| Dilon Technologies, INC. | $162.69 | 2025 | Hemoblast Bellows |
| Kerecis Limited | $144.07 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Janssen Biotech, INC. | $116.50 | 2022 | |
| Abbvie INC. | $112.74 | 2020-2022 | |
| E.R. Squibb & Sons, L.L.C. | $111.11 | 2021 | |
| Ethicon US, LLC | $106.46 | 2019-2025 | Echelon; Endopath |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Angiodynamics, INC. | $62.65 | 2022 | |
| Teleflex LLC | $41.58 | 2025 | Quikclot |
| Medtronic, INC. | $39.71 | 2024 | Signia |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Curran listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.